Tag: Stem Cells
Use of Novel Therapy, Stem Cell Transplant in MM Varies by Race
African-Americans, Hispanics have longer time from MM diagnosis to novel therapy initiation than whites
Salvage Therapy Does Not Up Survival for Progressive Myeloma
Deepening of response through salvage therapy not linked to improved progression-free, overall survival
ASCT May Offer Alternative for Tx of High-Risk Follicular Lymphoma
Autologous stem cell transplantation explored for high-risk, early therapy failure FL prior to rituximab use
Two-Dose Course of Vaccine After HSCT Cuts Incidence of Zoster
Incidence of herpes zoster decreased during median 21-month follow-up after autologous HSCT
Allo-HCT With Unrelated Donor Tied to Better Outcomes in AML
In active AML, outcomes superior for allo-HCT with unrelated donor than for cord blood transplantation
Experts Develop Standardized Tool for Describing Cell Therapies
Consensus reached on contents of DOSES tool for improving standardization and transparency
Population Mortality Affects Long-Term Follow-Up of AlloHCT
Substantial part of total nonrelapse mortality for older patients due to population mortality
Recommendations Issued for HSCT in Multiple Myeloma
Autologous stem cell transplant remains essential component of MM therapy in eligible patients
Favorable Outcomes Seen in Long Term for ALLR3 Trial
Findings for risk-stratified tx in B-cell precursor acute lymphoblastic leukemia, late bone marrow relapse
Second Man HIV-Free After Stem Cell Transplant
Donor had double copy of gene mutation that confers natural resistance to HIV
